U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Search Current & Recent Grants > Impact of asymptomatic sexually transmitted infections and interferon agonists on the susceptibility of foreskin primary cells to HIV‐1 infection Print

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov​.

Development of an HIV infection model of human foreskin to obtain novel insights into virus transmission

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Emerging Global Leader

Project Information in NIH RePORTER

Development of an HIV infection model of human foreskin to obtain novel insights into virus transmission

Principal Institution

International Centre for Genetic Engineering and Biotechnology

Principal Investigator(s) (PI)

Chigorimbo-Tsikiwa, Nyaradzo Tsitsi

Project Contact Information

Email: nyaradzo.chigorimbo-tsikiwa@uct.ac.za

Year(s) Awarded

2020-2025

Country

South Africa

Collaborators

Cornell University
Ulm University

Project Description

This project will establish which HIV immune target cell populations found in the human foreskin can be infected with HIV-1. The objective is to identify molecular pathways and activation signals that determine this susceptibility and whether a male with an asymptomatic sexually transmitted infection has enhanced susceptibility. Repurposing interferon agonists will be assessed for activity as antivirals in human foreskin and other cells.

Related World Regions / Countries

Related Global Health Research Topics